Cited by 610Herpesvirus Infections and TreatmentsInfectious Encephalopathies and EncephalitisCytomegalovirus and herpesvirus research

ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITIS

Sköldenberg, Birgit, Alestig, Kjell, Burman, Lars, Forkman, Anders, Lövgren, Kerstin, Norrby, Ragnar, Stiernstedt, Göran, Forsgren, Marianne +7 more·1984·The Lancet

Abstract

127 patients with suspected herpes simplex encephalitis (HSE) were entered in a prospective randomised study of acyclovir 10 mg/kg 8-hourly versus vidarabine 15 mg/kg daily for 10 days. The patients were consecutive and nearly all Swedish cases of HSE were included; they were treated in six university infectious diseases departments. The diagnosis of HSE was verified by brain biopsy and/or antibody responses in serum and cerebrospinal fluid. Of 53 confirmed cases of HSE (corresponding to 2 X 3 cases per million inhabitants per year in Sweden), 51 (27 acyclovir, 24 vidarabine) were evaluable for analysis of efficacy. The mortality was 19% in the acyclovir-treated group versus 50% in the vidarabine group (p = 0.04). At 6 months of observation 15 (56%) of 27 acyclovir-treated patients had returned to normal life compared with 3 (13%) of 24 vidarabine-treated patients (p = 0.002); and the numbers who died or had severe sequelae were 9 (33%) and 19 (76%), respectively (p = 0.005). No important or new adverse events were recognised.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(84)92623-0

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sköldenberg, B., Alestig, K., Burman, L., Forkman, A., Lövgren, K., Norrby, R., Stiernstedt, G., Forsgren, M., Bergström, T., Dahlqvist, E., Frydén, A., Norlin, K., Olding-Stenkvist, I., Uhnoo, I., & De Vahl, K.
Venue
The Lancet
Publisher
Elsevier BV
Published
1984-09
Volume
324
Issue
8405
Pages
707-711
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2149507482
Cited by
610
References
26
Citations by year
2026: 6 · 2025: 20 · 2024: 16 · 2023: 13 · 2022: 12 · 2021: 14 · 2020: 7 · 2019: 14 · 2018: 10 · 2017: 16 · 2016: 15 · 2015: 15 · 2014: 16 · 2013: 12 · 2012: 12
FWCI
28.98
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Epidemiology › Herpesvirus Infections and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Keywords
herpes simplex encephalitis, acyclovir, vidarabine, antiviral therapy, drug efficacy comparison, mortality, functional outcome, adverse events, Sweden
MeSH terms
Acyclovir, Adolescent, Adult, Aged, Antibodies, Viral, Brain, Child, Child, Preschool, Clinical Trials as Topic, Double-Blind Method, Encephalitis, Follow-Up Studies, Herpes Simplex, Humans, Infant, Infant, Newborn, Middle Aged, Prospective Studies, Random Allocation, Vidarabine, Simplexvirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review